Clinical Trials List
Protocol Number101-2333A
2012-10-01 - 2015-09-30
Others
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 吳宗翰 Division of Hematology & Oncology
- Pei-Hung Chang Division of Hematology & Oncology
- Sheng-Chieh Chan Division of Nuclear Medicine
- 賴建宏 Division of Hematology & Oncology
- 葉光揚 Division of Hematology & Oncology
- 王正旭 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- 呂嘉偉 Division of Radiology
- Shu-Hang Ag Division of Radiology
- Shih-Hsin Chen Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
0 participants
